About Tripartite motif-containing protein 59
Tripartite motif-containing protein 59 (TRIM59) is a protein
from Homo sapiens identified by UniProt accession
Q8IWR1, 403 residues long.
MolForge cross-references it against 0 known binders and
142 disease associations.
Target properties
| Protein name | Tripartite motif-containing protein 59 |
| UniProt accession | Q8IWR1 |
| Gene | TRIM59 |
| Organism | Homo sapiens |
| Length | 403 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (142)
Diseases linked to this target (Open Targets).
- pulse pressure measurement · score 0.34
- systolic blood pressure · score 0.33
- HbA1c measurement · score 0.19
- apolipoprotein A 1 measurement · score 0.17
- glucose measurement · score 0.16
- high density lipoprotein cholesterol measurement · score 0.16
- eosinophil count · score 0.15
- total cholesterol measurement · score 0.13
- eosinophil percentage of leukocytes · score 0.12
- cardiovascular disease · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IWR1-F1 | alphafold | PREDICTED | 84.75 | — |
Amino-acid sequence (403 residues)
MHNFEEELTC PICYSIFEDP RVLPCSHTFC RNCLENILQA SGNFYIWRPL RIPLKCPNCR SITEIAPTGI ESLPVNFALR AIIEKYQQED HPDIVTCPEH YRQPLNVYCL LDKKLVCGHC LTIGQHHGHP IDDLQSAYLK EKDTPQKLLE QLTDTHWTDL THLIEKLKEQ KSHSEKMIQG DKEAVLQYFK ELNDTLEQKK KSFLTALCDV GNLINQEYTP QIERMKEIRE QQLELMALTI SLQEESPLKF LEKVDDVRQH VQILKQRPLP EVQPVEIYPR VSKILKEEWS RTEIGQIKNV LIPKMKISPK RMSCSWPGKD EKEVEFLKIL NIVVVTLISV ILMSILFFNQ HIITFLSEIT LIWFSEASLS VYQSLSNSLH KVKNILCHIF YLLKEFVWKI VSH
Explore Tripartite motif-containing protein 59 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets